Published in Blood Weekly, August 28th, 2003
According to Baxter, Advate is the first and only factor VIII made without any added human or animal plasma proteins and albumin in the cell culture process, purification, and final formulation, thereby eliminating the risk of infections caused by viruses that may be carried in these proteins.
Developed by Baxter, Advate is a genetically engineered, or recombinant, full-length clotting factor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.